Skip to content

Clinical Evaluation of a Normoproteic Diet

Clinical Evaluation of a Normoproteic Diet With Ultra High Temperature Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01303289
Acronym
STDUGR
Enrollment
60
Registered
2011-02-24
Start date
2006-02-28
Completion date
2007-12-31
Last updated
2011-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Insufficient Nutrition

Keywords

Total Enteral Nutrition, Severe insufficient nutrition, T-Diet plus Standard, Lipidic profile, Quality of life

Brief summary

The main objective of this trial is the clinical evaluation of a normoproteic diet, when this diet is used for total enteral nutrition in geriatric people. For 3 months,all the participants in the study will receive only tube feeding: The experimental group will receive the commercial preparation to evaluate (T-Diet Plus ®, Vegenat SA) and the control group will receive a standard diet (Jevity ®, Abbott Laboratories).

Detailed description

The project includes: * Product tolerance study: gastrointestinal and metabolic complications related to the product administration. * The monitoring of the intervention, and clinical and nutritional evaluation of the participants, including anthropometry, quality of life related to the health and clinical and nutritional status analytical evaluation (hematology and biochemistry). * The determination of the major biochemical variables related to the lipid profile and assessment of the antioxidant defense system, and also certain markers of metabolic syndrome and associated cardiovascular risk.

Interventions

DIETARY_SUPPLEMENTT-Diet plus Standard

T-Diet plus Standard is a complete balanced protein and energy oral nutrition supplement, indicated for the dietary management of patients with related malnutrition.

DIETARY_SUPPLEMENTJevity

JEVITY is a diet for tube-fed patients in the medium to long term, to varying degrees of malnutrition with gastrointestinal disorders.

Sponsors

Vegenat, S.A.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 65 years old, of both sex, receiving total enteral nutrition by tube. * Admitted to medically supervised institutions (homes, health centers). * Requirement for total enteral nutrition standard, at least 3 months. * Acceptance volunteer to participate in the study by signing the written informed consent (approved by the Ethics Committee of University Hospital Virgen de las Nieves).

Exclusion criteria

* Patients who receive drugs with lipid composition. * Unstable clinical situation. * Patients with terminal illness. * Refusal or physical or mental inability to cooperate in the study. * Participating in another study. * Other causes: social causes, humanitarian, non-cooperation, etc..

Design outcomes

Primary

MeasureTime frameDescription
Nutritional status evaluation6 monthsClinical evaluation of a comercial product: T-Diet Plus (normoproteic and specific diet), when is used for total enteral nutrition in geriatric people.

Secondary

MeasureTime frameDescription
Specific parameters measure6 months1. Confirm gastrointestinal and metabolic tolerance of the product. 2. Consider the influence of the diet received on quality of life related to health. 3. Study the changes in the nutritional status of elderly patients 4. Assess changes in the lipid profile of patients 5. Compare the evolution in blood levels of metabolic syndrome indicator parameters and other related to cardiovascular morbidity. 6. Assess changes in the antioxidant defense system.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026